إعلان
FULC أخبار الفوركس
Fulcrum Therapeutics Names Robert Gould As Interim CEO After CEO Bryan Stuart Departs
Biopharmaceutical company Fulcrum Therapeutics, Inc. (FULC) announced Wednesday that Robert Gould, former president and founding chief executive officer, has been appointed as interim CEO, effective January 3, 2023. He is also a current member of the Board of Directors.
RTTNews
|
1347 منذ أيام
